Instrument Inactif

Autres langues Biocartis Group NV

Actions

BCART

BE0974281132

Equipement, fournitures et distribution médicale

PEA

PEA/PME

Autres langues

24/03	Biocartis, Medical College of Wisconsin Enter Research Collaboration for Breast Cancer Gene Signature Test Development
11/03	Biocartis Receives European IVDR Certification for the Idylla CDx MSI Test
18/12	BIOCARTIS : ANNOUNCES JUDICIAL DISSOLUTION AND APPOINTMENT OF A LIQUIDATOR
18/12	BIOCARTIS : KONDIGT GERECHTELIJKE ONTBINDING EN AANSTELLING VAN EEN VEREFFENAAR AAN
16/09/25	Biocartis' Colorectal Cancer Test Wins US FDA Approval
15/09/25	Biocartis Receives FDA Approval for the Idylla?? CDx MSI Test
26/08/25	Aandeelhouders Biocartis stemmen in met ontbinding
26/08/25	Biocartis : RESULTATEN VAN DE ALGEMENE AANDEELHOUDERSVERGADERING GEHOUDEN OP 25 AUGUSTUS 2025
26/08/25	Biocartis : RESULTS OF THE ANNUAL GENERAL SHAREHOLDERS' MEETING HELD ON 25 AUGUST 2025
18/08/25	Biocartis : Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development
28/07/25	Biocartis : Algemene vergadering
28/07/25	Biocartis : General meeting
17/07/25	Biocartis Group NV Reports Earnings Results for the Full Year Ended December 31, 2023
03/04/25	Biocartis Announces Launch of the Brand-New Idylla POLE-POLD1 Mutation Assay
18/03/25	Biocartis : Announces Multiple Abstracts Demonstrating the Impact of Idylla™ in Oncology Diagnostics to be Presented at USCAP 2025 Annual Meeting
17/02/25	Biocartis announces new data on early CAR-T vector load assessment with Idylla presented at ASTCT, A Potential Breakthrough in LBCL Treatment Monitoring
14/02/25	Biocartis announces new data on early CAR-T vector load assessment with Idylla presented at ASTCT: A Potential Breakthrough in LBCL Treatment Monitoring
06/11/24	Molecular Diagnostic Company Biocartis Names CFO
23/10/24	Biocartis : announces six Idylla™ abstracts to be presented at AMP 2024 Annual Meeting
10/06/24	Biocartis Names Chief Business Officer
10/06/24	Biocartis NV Appoints Gina Wallar as Chief Business Officer
15/05/24	FSMA waarschuwt voor laattijdig publiceren jaarverslag
09/05/24	Biocartis stelt publicatie jaarverslag uit
09/05/24	Persbericht Biocartis Group NV: Biocartis Group NV brengt een update rond de publicatie van haar jaarverslag en de jaarlijkse algemene vergadering
09/05/24	Press release Biocartis Group NV: Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting